DJIA 18,214.42 -10.15 -0.06%
NASDAQ 4,987.89 20.75 0.42%
S&P 500 2,110.74 -3.12 -0.15%
market minute promo

GlaxoSmithKline (NYSE: GSK)

company name or ticker
Company Photos
(Click to zoom)

Pharmaceuticals Remain In The Spotlight - Cramer's Lightning Round (2/5/15)

6.73% Edge For 5 Healthcare Lowest-Priced, High-Yield January Dividend Dogs

Theravance Royalty Revenue Forecast

Glaxo Posts In Line Q4 Earnings, HIV Segment Sales Grow - Analyst Blog

European Stocks Move Lower as ECB Won't Accept Greek Bonds

10 Hardy Healthcare Dividend Dogs Hit 20% Mean January Upsides

5 Stocks Our Analysts Recently Bought

What companies are these Fool's buying a stake in with their own money? Here are five stocks they recently bought.

GLAXOSMITHKLINE PLC (GSK) Earnings Report: Q4 2014 Conference Call Transcript

GlaxoSmithKline PLC Earnings: Finally Turning a Corner?

GlaxoSmithKline's fourth-quarter sales and profits weren't particularly encouraging, but this solitary aspect could signal that it's put the worst in the rearview mirror.

GlaxoSmithKline (GSK) CEO Andrew Witty on Q4 2014 Results - Earnings Call Transcript

See More Articles...